Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
about
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilitiesCannabinoids as therapeutic agents in cancer: current status and future implicationsThe CB2 receptor and its role as a regulator of inflammationβ-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsCannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in miceThe cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesityFunctions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.
P2860
Q24623282-DFD712BE-BB21-490E-BB15-036164A6CD06Q26866298-83730C16-AFE5-4EFC-BA59-9DEB7927709AQ28066700-BA0EE1E8-7133-4284-BC07-BB7B7CE4F515Q35854652-8A2FF702-28BC-4744-8C4A-9C17AA8391E2Q35887816-442ACAC9-8B34-4F36-AC68-B6BB14B4114DQ36089227-9077301E-94EE-4F9B-80C1-7ACF073EBB53Q36203242-6FFD9379-851D-4B5C-95B5-A98C72DAF805Q36718218-CF4839AF-20AE-46D6-8714-A09E3F97D2C2Q36900366-FC1BF3A3-0C89-49A1-91BA-DF8C5A684E22Q38220272-C4ADBABC-91A0-43BD-AFC4-CCFE8B814CAAQ38455748-F4D77233-6B56-4A76-B557-39C5EED53613Q39077570-D1BA9397-7C30-4248-86A1-F6E7C6C5198B
P2860
Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@ast
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@en
type
label
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@ast
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@en
prefLabel
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@ast
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@en
P2093
P2860
P50
P921
P1476
Δ8-Tetrahydrocannabivarin prev ...... ugh cannabinoid CB2 receptors.
@en
P2093
Anu Mahadevan
Aron H Lichtman
Bėla Horváth
Lisa A Gauson
Mohanraj Rajesh
Mukkanti Amere
Natalia Battista
Rachel Y Gao
Sándor Bátkai
P2860
P304
P356
10.1111/J.1476-5381.2011.01410.X
P407
P577
2012-04-01T00:00:00Z